Ticagrelor-Based Antiplatelet Regimens in Patients Treated With Coronary Artery Bypass Grafting: A Meta-Analysis of Randomized Controlled Trials

The authors present a meta-analysis of randomized controlled trials regarding the outcome of ticagrelor-based antiplatelet therapies in patients after coronary artery bypass graft (CABG) surgery. They found a reduced rate of major adverse cardiac events and a reduced mortality in these patients receiving aspirin and/or clopidogrel. This finding should be investigated in randomized trials, as it could potentially change the standard of care of CABG patients.